• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Clinical characteristics and molecular epidemiology associated with imipenem-resistant Klebsiella pneumoniae.

作者信息

Ahmad M, Urban C, Mariano N, Bradford P A, Calcagni E, Projan S J, Bush K, Rahal J J

机构信息

New York Hospital Medical Center of Queens, Flushing, New York 11355-5095, USA.

出版信息

Clin Infect Dis. 1999 Aug;29(2):352-5. doi: 10.1086/520214.

DOI:10.1086/520214
PMID:10476741
Abstract

Eight patients were infected or colonized with imipenem-resistant Klebsiella pneumoniae (IRKP) from December 1994 to November 1995. Initial Klebsiella isolates were susceptible to imipenem but resistant to all cephalosporins, aminoglycosides, and beta-lactam inhibitor combinations. All patients had been in the surgical intensive care unit and had undergone abdominal surgery or tracheostomy during hospitalization. The average age of the patients was 71 years (range, 41-81 years). All patients were treated with imipenem for 5 to 36 days, and IRKP was recovered from each during or after therapy. Pulsed-field gel electrophoresis (PFGE) of the IRKP isolates revealed three distinct clonal patterns. Paired sequential isolates of imipenem-susceptible K. pneumoniae and IRKP from two patients had identical PFGE patterns, suggesting the development of clonal stepwise resistance to imipenem during therapy. Thus, imipenem resistance in Klebsiella may occur when this agent is used for treatment of infection due to ceftazidine- and aminoglycoside-resistant strains.

摘要

相似文献

1
Clinical characteristics and molecular epidemiology associated with imipenem-resistant Klebsiella pneumoniae.
Clin Infect Dis. 1999 Aug;29(2):352-5. doi: 10.1086/520214.
2
Clonal spread of KPC-2 carbapenemase-producing Klebsiella pneumoniae strains in Greece.产KPC-2碳青霉烯酶肺炎克雷伯菌菌株在希腊的克隆传播。
J Antimicrob Chemother. 2009 Aug;64(2):348-52. doi: 10.1093/jac/dkp207. Epub 2009 Jun 13.
3
[Molecular epidemiology of carbapenem-resistant Klebsiella pneumoniae strains isolated between 2004-2007 in Ankara University Hospital, Turkey].[2004年至2007年期间在土耳其安卡拉大学医院分离出的耐碳青霉烯类肺炎克雷伯菌菌株的分子流行病学研究]
Mikrobiyol Bul. 2010 Jan;44(1):1-10.
4
Molecular investigation of two clusters of hospital-acquired bacteraemia caused by multi-resistant Klebsiella pneumoniae using pulsed-field gel electrophoresis and in frequent restriction site PCR. Infection Control Group.运用脉冲场凝胶电泳和稀有切割位点聚合酶链反应对两起由多重耐药肺炎克雷伯菌引起的医院获得性菌血症聚集病例进行分子研究。感染控制组
J Hosp Infect. 2000 Oct;46(2):110-7. doi: 10.1053/jhin.2000.0815.
5
Emergence in Japan of an imipenem-susceptible, meropenem-resistant Klebsiella pneumoniae carrying blaIMP-6.在日本出现了一株对亚胺培南敏感、对美罗培南耐药的携带 blaIMP-6 的肺炎克雷伯菌。
Diagn Microbiol Infect Dis. 2012 Jan;72(1):109-12. doi: 10.1016/j.diagmicrobio.2011.09.019. Epub 2011 Nov 10.
6
Expansion and countrywide dissemination of ST11, ST15 and ST147 ciprofloxacin-resistant CTX-M-15-type beta-lactamase-producing Klebsiella pneumoniae epidemic clones in Hungary in 2005--the new 'MRSAs'?2005年匈牙利ST11、ST15和ST147型耐环丙沙星且产CTX-M-15型β-内酰胺酶的肺炎克雷伯菌流行克隆的传播与全国扩散——新的“耐甲氧西林金黄色葡萄球菌”?
J Antimicrob Chemother. 2008 Nov;62(5):978-85. doi: 10.1093/jac/dkn287. Epub 2008 Jul 30.
7
Outbreak caused by a multidrug-resistant Klebsiella pneumoniae clone carrying blaVIM-12 in a university hospital.一所大学医院中由携带blaVIM - 12的多重耐药肺炎克雷伯菌克隆引起的暴发。
J Clin Microbiol. 2008 Mar;46(3):1005-8. doi: 10.1128/JCM.01573-07. Epub 2008 Jan 16.
8
Molecular epidemiology and risk factors of bloodstream infections caused by extended-spectrum beta-lactamase-producing Klebsiella pneumoniae A case-control study.产超广谱β-内酰胺酶肺炎克雷伯菌所致血流感染的分子流行病学及危险因素:一项病例对照研究
Int J Infect Dis. 2008 Nov;12(6):653-9. doi: 10.1016/j.ijid.2008.03.008. Epub 2008 Jun 3.
9
First outbreak of multidrug-resistant Klebsiella pneumoniae carrying blaVIM-1 and blaSHV-5 in a French university hospital.法国一家大学医院首次爆发携带blaVIM-1和blaSHV-5的耐多药肺炎克雷伯菌。
J Antimicrob Chemother. 2006 Jan;57(1):142-5. doi: 10.1093/jac/dki389. Epub 2005 Nov 10.
10
Molecular epidemiology and antimicrobial susceptibility of extended- and broad-spectrum beta-lactamase-producing Klebsiella pneumoniae isolated in Portugal.葡萄牙分离出的产超广谱β-内酰胺酶和广谱β-内酰胺酶肺炎克雷伯菌的分子流行病学及抗菌药敏性
Int J Antimicrob Agents. 2009 Jul;34(1):29-37. doi: 10.1016/j.ijantimicag.2008.11.014. Epub 2009 Mar 9.

引用本文的文献

1
Systematic review and meta-analysis of mortality of patients infected with carbapenem-resistant Klebsiella pneumoniae.耐碳青霉烯类肺炎克雷伯菌感染患者死亡率的系统评价与荟萃分析
Ann Clin Microbiol Antimicrob. 2017 Mar 29;16(1):18. doi: 10.1186/s12941-017-0191-3.
2
Risk factors of carbapenem-resistant Klebsiella pneumoniae infection: a serious threat in ICUs.耐碳青霉烯类肺炎克雷伯菌感染的危险因素:重症监护病房中的严重威胁。
Med Sci Monit. 2015 Jan 17;21:219-24. doi: 10.12659/MSM.892516.
3
Risk factor analysis for extended-spectrum β-lactamase-producing Enterobacter cloacae bloodstream infections in central Taiwan.
台湾中部产超广谱β-内酰胺酶阴沟肠杆菌血流感染的危险因素分析
BMC Infect Dis. 2013 Sep 8;13:417. doi: 10.1186/1471-2334-13-417.
4
Treatment of complicated urinary tract infections with an emphasis on drug-resistant gram-negative uropathogens.治疗复杂性尿路感染,重点关注耐药革兰阴性尿路病原体。
Curr Infect Dis Rep. 2013 Apr;15(2):109-15. doi: 10.1007/s11908-013-0315-7.
5
Risk factors and clinical impact of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae.产碳青霉烯酶肺炎克雷伯菌的危险因素和临床影响。
Infect Control Hosp Epidemiol. 2009 Dec;30(12):1180-5. doi: 10.1086/648451.
6
AmpC beta-lactamases.AmpC β-内酰胺酶
Clin Microbiol Rev. 2009 Jan;22(1):161-82, Table of Contents. doi: 10.1128/CMR.00036-08.
7
Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality.住院成人中耐碳青霉烯类肺炎克雷伯菌感染的预测因素及感染对死亡率的影响。
Antimicrob Agents Chemother. 2008 Mar;52(3):1028-33. doi: 10.1128/AAC.01020-07. Epub 2007 Dec 17.
8
Clinical correlation of the CLSI susceptibility breakpoint for piperacillin- tazobactam against extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella species.哌拉西林-他唑巴坦对产超广谱β-内酰胺酶大肠埃希菌和克雷伯菌属的CLSI药敏折点的临床相关性
Antimicrob Agents Chemother. 2006 Jun;50(6):2244-7. doi: 10.1128/AAC.00381-05.
9
Effect of antibiotic heterogeneity on the development of infections with antibiotic-resistant gram-negative organisms in a non-intensive care unit surgical ward.抗生素异质性对非重症监护病房外科病房革兰氏阴性耐药菌感染发生的影响。
World J Surg. 2006 Jul;30(7):1269-76. doi: 10.1007/s00268-005-0781-7.
10
Nosocomial pneumonia : rationalizing the approach to empirical therapy.医院获得性肺炎:优化经验性治疗方法
Treat Respir Med. 2006;5(1):11-30. doi: 10.2165/00151829-200605010-00002.